Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer. Read more about Mechanisms of Resistance to Neoadjuvant Chemotherapy in Breast Cancer.
Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection. Read more about Sofosbuvir, Velpatasvir, and Voxilaprevir for Previously Treated HCV Infection.
Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery. Read more about Levosimendan in Patients with Left Ventricular Dysfunction Undergoing Cardiac Surgery.
Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma. Read more about Pembrolizumab as Second-Line Therapy for Advanced Urothelial Carcinoma.
Myocarditis with Immune Checkpoint Blockade. Read more about Myocarditis with Immune Checkpoint Blockade.
Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B. Read more about Multisystem Anomalies in Severe Combined Immunodeficiency with Mutant BCL11B.
Palbociclib and Letrozole in Advanced Breast Cancer. Read more about Palbociclib and Letrozole in Advanced Breast Cancer.
Fulminant Myocarditis with Combination Immune Checkpoint Blockade. Read more about Fulminant Myocarditis with Combination Immune Checkpoint Blockade.
